Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition

Jia Yu, Jenna Brown, Eli Salzberg, Aria Wei, Gloria Gerber, Xiang-Zuo Pan, Alison R. Moliterno, MIchael B. Streiff, Peggy Kraus, Claire Logue, Jennifer Yui, Rakhi P.P. Naik, Hira Latif, Sophie M. Lanzkron, Evan M. Braunstein, Robert Brodsky, Michael R. DeBaun, Doris Lin, Shruti Chaturvedi

Blood (2022) 140 (Supplement 1): 338–340.

https://doi.org/10.1182/blood-2022-167054

Published: 2022

Journal Articles

Alternative Bone Marrow Transplantation with Post-Transplant Cyclophosphamide (PTCy) As Initial Therapy for Acquired Severe Aplastic Anemia (SAA)

Amy E. DeZern, Marianna Zahurak, Kenneth R. Cooke, Richard J. Jones, Robert Brodsky

Blood (2022) 140 (Supplement 1): 4868–4869.

https://doi.org/10.1182/blood-2022-157861

Published: 2022

Journal Articles

Prospective Study of Complement Activation with Functional and Genetic Assays in Sickle Cell Disease

Christos Varelas, Efthymia Vlachaki, Filippos Klonizakis, Despoina Pantelidou, Fani Minti, Michael D. Diamantidis, Nikolaos Sampanis, Ioanna Giatagantzidou, Despoina Papadopoulou, Evdoxia Koravou, Ioanna Christodoulou, Evaggelia Zarkada, Tasoula Touloumenidou, Apostolia Papalexandri, Ioanna Sakellari, George Vassilopoulos, Robert Brodsky, Eleni Gavriilaki

Blood (2022) 140 (Supplement 1): 2504–2505.

https://doi.org/10.1182/blood-2022-164554

Published: 2022

Journal Articles

Pathogenicity of Sars-Cov-2 Spike Protein Variants Correlates with Coagulation and Complement Assays

Gloria Gerber, Xiang-Zuo Pan, Nikhil Ranjan, Anna Warmack, Robert Brodsky

Blood (2022) 140 (Supplement 1): 2705–2706.

https://doi.org/10.1182/blood-2022-169738

Published: 2022

Journal Articles

Abundance of B Cell Receptors Harboring Elongated Polytyrosine and Polyserine Rich Motifs within Their Heavy Chain CDR3 Distinguishes Catastrophic and Antiphospholipid Syndrome

Shadi Swaidani, Shruti Chaturvedi, Xiang-Zuo Pan, Robert Brodsky, Renren Wen, Alok A Khorana, Keith R. McCrae

Blood (2021) 138 (Supplement 1): 2117.

https://doi.org/10.1182/blood-2021-148158

Published: 2021

Journal Articles

Prevalence and Characteristics of Venous Thromboembolism in Patients with Complement Mediated Thrombotic Microangiopathy

Aria Wei, Gloria Frances Gerber, Kathryn Dane, Evan M. Braunstein, Robert Brodsky, Shruti Chaturvedi

Blood (2021) 138 (Supplement 1): 2091.

https://doi.org/10.1182/blood-2021-152904

Published: 2021

Journal Articles

Silent Cerebral Infarction on Brain MRI Is Associated with Cognitive Impairment in Ittp Survivors in Hematological Remission

Jia Yu, Aria Wei, Xiang-Zuo Pan, Gloria Frances Gerber, Sarah Hussain, Alison R. Moliterno, Michael B. Streiff, Peggy Kraus, Claire Logue, Jennifer Yui, Rakhi P. Naik, Hira Latif, Ruhail Kohli, Sophie M. Lanzkron, Evan M. Braunstein, Robert Brodsky, Doris Lin, Shruti Chaturvedi

Blood (2021) 138 (Supplement 1): 774.

https://doi.org/10.1182/blood-2021-151304

Published: 2021

Journal Articles

Outcomes of a Clinician-Directed Protocol for Discontinuation of Complement Inhibition Therapy in Atypical Hemolytic Uremic Syndrome

Noor Dhaliwal, Sarah Hussain, Harshvardhan Upreti, Evan M Braunstein, MDPhD, Xuan Yuan, MD MSc, Alison R. Moliterno, MD, Robert Brodsky, MD, Shruti Chaturvedi, MBBS,MS

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-142965

Published: 2020

Journal Articles

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Adetola A. Kassim, MDMS, Josu de la Fuente, Ali Debsan Alahmari, MBBS, MD MNAMS, Michael J. Eckrich, MD MPH, Rabi Hanna, MD, Nathalie Dhedin, MD, Biljana N. Horn, MD, Vandy Black, MDMSc, Roseane V Gouveia, Adriana Seber, MDMS, Belinda Pinto Simões, MD PhD, Thalita Cristina de Mello Costa, MD, Renato Guerino-Cunha, Carmem M. S. Bonfim, MDPhD, Roberto Luiz da Silva, Nelson Hamerschlak, MD PhD, Juliana Folloni Fernandes, MD, Michael Kent, MDBS, Satya Prakash Yadav, MBBS, MD, Erfan Nur, MDPhD, Mohsen Alzahrani, Ben Carpenter, PhD, William Tse, MD, Maria Isabel, Hemalatha G Rangarajan, MD, Ibrahim Ahmed, MD, Adeseye Michael Akinsete, MBBS, Courtney D. Fitzhugh, MD, Kathryn A. Culos, PharmD, Leena Karnik, FRCPath, MRCP, James Connelly, MD, Carrie Kitko, MD, Jennifer Andrews, MDMSc, Karina L Wilkerson, NP, MSN, Robert Brodsky, Tatsuki Koyama, Michael R. DeBaun, MD MPH

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-141771

Published: 2020

Journal Articles

Defects in Sialic Acid Biosynthesis Cause Dysregulation of the Alternative Pathway of Complement

Hang Chen, Luyi Peng, Jia Yu, BS, Xuan Yuan, MD MSc, Shruti Chaturvedi, MBBS,MS, Robert Brodsky, MD, Evan M Braunstein, MDPhD

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-141289

Published: 2020

Journal Articles

Phase 3 Study of Danicopan, an Oral Complement Factor D Inhibitor, As Add-on Therapy to a C5 Inhibitor in Patients with Paroxysmal Nocturnal Hemoglobinuria with Clinically Evident Extravascular Hemolysis

Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Antonio Risitano, Jong Wook Lee, MD, PhD, Mingjun Huang, PhD, Jun-Ichi Nishimura, MD PhD, Alejandra Ramirez-Santiago, Robert Brodsky

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-134388

Published: 2020

Journal Articles

Single-board hematology fellowship track: a 10-year institutional experience

Rakhi P. Naik, Kristen Marrone, Samuel Merrill, Ross Donehower, Robert Brodsky

Blood (2018) 131 (4): 462–464.

https://doi.org/10.1182/blood-2017-11-816207

Published: 2018

Journal Articles

Complement Blockade With a C1 Esterase Inhibitor In Paroxysmal Nocturnal Hemoglobinuria

Amy E. DeZern, MD, MHS, Marc Uknis, MD, PhD, Galina Mukhina, MD, PhD, Jo Anne Saye, PhD, Jeffrey J Pu, MD, PhD, Robert Brodsky, MD

Blood (2013) 122 (21): 594.

https://doi.org/10.1182/blood.V122.21.594.594

Published: 2013

Journal Articles

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Leo Luznik, Javier Bolaños-Meade, Marianna Zahurak, Allen R. Chen, B. Douglas Smith, Robert Brodsky, Carol Ann Huff, Ivan Borrello, William Matsui, Jonathan D. Powell, Yvette Kasamon, Steven N. Goodman, Allan Hess, Hyam I. Levitsky, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs

Blood (2010) 115 (16): 3224–3230.

https://doi.org/10.1182/blood-2009-11-251595

Published: 2010

Journal Articles

Anti-Leukemic Activity of Mitochondrially-Directed Asymmetrical 2-2'-Binaphthoquinones.

Rebecca Ricklis, MSc, Milena Vuica-Ross, MD, Robert Brodsky, MD, Ed Sausville, MD, PhD, Chi Van Dang, MD, PhD, Judith E Karp, MD, Ashkan Emadi, MD, PhD

Blood (2009) 114 (22): 4799.

https://doi.org/10.1182/blood.V114.22.4799.4799

Published: 2009

Journal Articles

High Dose Cyclophosphamide (HD CY) without Hematopoietic Stem Cell Transplantation (HSCT) in Refractory Severe Autoimmune Diseases: 11 Year Experience in Over 100 Patients.

Amy E. DeZern, MD, Michelle Petri, MD, Douglas Kerr, MD, Daniel Drachman, MD, Adam Kaplin, MD, PhD, Charles Hesdorffer, MBBCH, FCP(SA), Grant Anhalt, MD, Fredrick Wigley, MD, Richard J. Jones, MD, Robert Brodsky, MD

Blood (2009) 114 (22): 3412.

https://doi.org/10.1182/blood.V114.22.3412.3412

Published: 2009

Journal Articles

A Global Registry of Patients with Paroxysmal Nocturnal Hemoglobinuria.

Robert Brodsky, Hubert Schrezenmeier, MD, Petra Muus, MD, PhD, Monica Bessler, MD, PhD, Jeffrey Szer, MBBS, FRACP, Bruno Rotoli, MD, Jaroslaw P. Maciejewski, MD, PhD, Gerard Socie, MD, PhD, A. Urbano-Ispizua, MD, Wendell F. Rosse, MD, Yuzuru Kanakura, MD, PhD, Anders Karnell, Camille Bedrosian, MD, Peter Hillmen, MB, ChB, PhD

Blood (2009) 114 (22): 3007.

https://doi.org/10.1182/blood.V114.22.3007.3007

Published: 2009

Journal Articles

Modification of the Eculizumab Dose to Successfully Manage Intravascular Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Richard Kelly, MD, Louise Arnold, BSc, MA, Stephen Richards, PhD, Anita Hill, MD, Sandra vanBijnen, MD, Petra Muus, MD, PhD, Donna Dorr, RN, MSN, AOCN, Robert Brodsky, MD, Gus Khursigara, PhD, Russell P. Rother, PhD, Peter Hillmen, MBChB, PhD

Blood (2008) 112 (11): 3441.

https://doi.org/10.1182/blood.V112.11.3441.3441

Published: 2008

Journal Articles

Post-Transplantation High Dose Cyclophosphamide (Cy) Is Effective Single Agent for Prevention of Acute and Chronic Graft Versus Host Disease after Myeloablative HLA Matched Related and Unrelated Bone Marrow Transplantation (BMT)

Leo Luznik, Javier Bolanos-Meade, Robert Brodsky, B. Douglas Smith, Carol A. Huff, Michele Kaup, Allen Chen, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs

Blood (2008) 112 (11): 56.

https://doi.org/10.1182/blood.V112.11.56.56

Published: 2008

NARROW

Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition

Alternative Bone Marrow Transplantation with Post-Transplant Cyclophosphamide (PTCy) As Initial Therapy for Acquired Severe Aplastic Anemia (SAA)

Prospective Study of Complement Activation with Functional and Genetic Assays in Sickle Cell Disease

Pathogenicity of Sars-Cov-2 Spike Protein Variants Correlates with Coagulation and Complement Assays

Abundance of B Cell Receptors Harboring Elongated Polytyrosine and Polyserine Rich Motifs within Their Heavy Chain CDR3 Distinguishes Catastrophic and Antiphospholipid Syndrome

Prevalence and Characteristics of Venous Thromboembolism in Patients with Complement Mediated Thrombotic Microangiopathy

Silent Cerebral Infarction on Brain MRI Is Associated with Cognitive Impairment in Ittp Survivors in Hematological Remission

Outcomes of a Clinician-Directed Protocol for Discontinuation of Complement Inhibition Therapy in Atypical Hemolytic Uremic Syndrome

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Defects in Sialic Acid Biosynthesis Cause Dysregulation of the Alternative Pathway of Complement

Phase 3 Study of Danicopan, an Oral Complement Factor D Inhibitor, As Add-on Therapy to a C5 Inhibitor in Patients with Paroxysmal Nocturnal Hemoglobinuria with Clinically Evident Extravascular Hemolysis

Single-board hematology fellowship track: a 10-year institutional experience

Complement Blockade With a C1 Esterase Inhibitor In Paroxysmal Nocturnal Hemoglobinuria

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Anti-Leukemic Activity of Mitochondrially-Directed Asymmetrical 2-2'-Binaphthoquinones.

High Dose Cyclophosphamide (HD CY) without Hematopoietic Stem Cell Transplantation (HSCT) in Refractory Severe Autoimmune Diseases: 11 Year Experience in Over 100 Patients.

A Global Registry of Patients with Paroxysmal Nocturnal Hemoglobinuria.

Modification of the Eculizumab Dose to Successfully Manage Intravascular Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Post-Transplantation High Dose Cyclophosphamide (Cy) Is Effective Single Agent for Prevention of Acute and Chronic Graft Versus Host Disease after Myeloablative HLA Matched Related and Unrelated Bone Marrow Transplantation (BMT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only